The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Conditions: Paroxysmal Atrial Fibrillation Interventions: Device: Ablation Procedure Sponsors: Heart Rhythm Clinical and Research Solutions, LLC; Biosense Webster, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials